Simplex P Bone Cement
Celebrates 50 Years of Achievement
Stryker Orthopaedics’ line of Simplex P products supports a range of surgical procedures including primary and revision surgery for hips, knees and shoulders. The line includes Simplex P, the Company’s original bone cement; Simplex P SpeedSet, which is designed to set faster than the original; and Simplex P with Tobramycin, which contains antibiotics.*
Designed to Provide Excellent Results
We designed the Simplex line to provide the right ingredients in the right formula to balance unrivaled strength with consistent handling for excellent intra-operative and long-term results.¹
One of Many Milestones
Simplex has achieved many milestones during its 50-year tenure, including: the implantation of more than 25,000,000 doses, use in more than 4,000 hospitals and coverage in more than 600 research journals.² Simplex P bone cements offer our surgeon customers confidence, versatility and clinical performance.
On the Forefront of Bone Cement Advancement
“Over the years, Stryker has proactively stayed on the forefront of bone cement advancement, in both formulation and cementing technique,” said Mike Mogul, president of Stryker's Orthopaedics division. “The long tenure of Simplex and its position as a top bone cement product is a testament to Stryker’s understanding of the current and future needs of the orthopaedic market.”
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademark(s) or service mark(s): Simplex P, Simplex P with Tobramycin, SpeedSet. All other trademarks are trademarks of their respective owners or holders.
*Antibiotic bone cement is cleared by the FDA for use in the second stage of a two-stage revision.
1. Havelin LI, Espenhaug B, Vollset Se, Engesaeter LB. The effect of the type of cement on the early revision of Charnley total hip prosthesis. J Bone J Surg. 1995: 1543 – 1550.
2. Sales data on file at Stryker Orthopaedics.